Limiting factors of exercise capacity in patients with COPD;Estudo dos factores limitativos do exercíco físico em doentes com doença pulmonar obstrutiva crónica

Revista Portuguesa de Pneumologia

Volumn 10, Issue 1, 2004, Pages 9-61

  Rodrigues, Fátima ^a  

^a HOSPITAL PULIDO VALENTE   (Portugal)

Author keywords

COPD; Exercise capacity; Gas exchange abnormalities; Lung hyperinflation; Ventilatory limitation

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; AGE; AGED; BODY MASS; BREATHING DISORDER; CARBON DIOXIDE TENSION; CARDIOPULMONARY HEMODYNAMICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DYNAMIC EXERCISE; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG INFLATION; MALE; METABOLISM; OXYGEN CONSUMPTION; OXYGEN TENSION; PREDICTION; RESPIRATORY TRACT PARAMETERS; REST; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TIDAL VOLUME; TREATMENT PLANNING; WORK CAPACITY;

EID: 1642283568     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30556-0     Document Type: Review

References (96)

1. AGUSTI AGN, COTES J, WAGNER PD. Responses to exercise in lung diseases in Clinical exercise testing, Roca J, Whipp BJ (Eds), Eur Respir Mon 1997, 6: 32-50.
2. AMERICAN THORACIC SOCIETY. Dyspnea. Mechanism, assessment and management: a consensus statement. Am J Respir Crit Care Med 1999; 159: 321-340.
3. AMERICAN THORACIC SOCIETY. Standardization of spirometry. 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
4. ANTHONISEN NR, MANFREDA J, WARREN CPW, et al. Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
5. BAARENDS EM, SCHOLS AMWJ, AKKERMANS MA, WOUTERS EFM. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax 1997, 52: 981-986.
6. BÁRBARA C, MOTA CARMO M, RENDAS AB, ÁVILA R. Controlo da ventilação. Acta Medica Portuguesa 1995; 8: 433-440.
7. BELLEMARE F, GRASSINO A. Effect of pressure and timing of contraction on human diaphragm fatigue. J Appl Physiol 1982; 53: 1190-1195.
8. BELMAN MJ, BOTNICK WC, SHIN JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. AM J Respir Crit Care Med 1996; 153: 967-975.
9. BENBASSAT J, FROOM P. Blood pressure response to exercise as a predictor of hypertension. Arch Intern Med 1986; 146: 2053-2055.
10. BLACK LF, HYATT RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696-702.
11. BLACKIE SP, FAIRBARN MS, MCELVANEY NG, WILCOX PG et al. Normal values and ranges for ventilation and breathing pattern at maximal exercise. Chest 1991; 100: 136-142.
12. BORG GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
13. CARLSON DJ, RIES AL, KAPLAN RM. Exercise tolerance in patient with COPD. Chest 1991; 100: 307-311.
14. CARTER R, PEAVLER M, ZINKGRAF S, WILLIAMS J, FIELDS S. Predicting maximal exercise ventilation in chronic obstructive pulmonary disease. Chest 1987; 92: 253-259.
15. CASABURI R, PORSZASZ J, BURNS MR, CARITHERS ER, CHANG RSY, COOPER CB. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541-1551.
16. CHONAN T, MULHOLLAND MB, LEITNER J, ALTOSE MD, CHERNIACK NS. Sensation of dyspnea during hipercapnia, and voluntary hyperventilation. J Appl Physiol 1990; 68 (5): 2100-2106.
17. CLANTON TL, DIXON G, DRAKE J, GADEK JE. Inspiratory muscle conditioning using a threshold loading device. Chest 1985; 87: 62-66.
18. Classification, Assessment, Surveys and Terminology Team of World Health Organization. International Classification of Functioning, Disability and Health. ICIDH-2 2001. Final draft. Full version. Internet: htpp://www.who.int/icidh.
19. COATES AL, PESLIN R, RODENSTEIN D et al. Measurement of lung volumes by plethysmography. Eur Respir J 1997; 10: 1415-1427.
20. CRAPO RO, HANKINSON JL et al. Single breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique. 1995 update. Am Rev Resp Dis 1995; 152: 2185-2198.
21. DANTZKER DR, D'ALONZO GE. The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134: 1135-1139.
22. DE TROYER A, LEEPER JB, MCKENZIE DK, GANDEVIA SC. Neural drive to the diaphragm in patients with severe COPD. Am J Respir Crit Care Med 1997; 155: 1335-1340.
23. DECRAMER M, STAS M. Corticosteroid-induced myopathy involving respiratory muscles in patients with COPD or asthma. Am Rev Respir Dis 1992; 146: 800-802.
24. DILLARD TA, PIANTADOSI S, RAJAGOPAL KR. Determinants of maximum exercise capacity in patients with chronic airflow obstruction. Chest 1989; 96(2): 267-271.
25. DOLMAGE TE, GOLDSTEIN RS. Proportional assist ventilation and exercise tolerance in subjects with COPD. Chest 1997; 111: 948-954.
26. EFTHIMIOU J, FLEMING J, GOMES C, et al. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 137: 1075-1082.
27. FIACCADORI E, DEL CANALE S, VITALI P, et al. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest 1987; 92: 883-887.
28. FISHMAN AP. Exercise, integration and adaptation. In Fishman's Pulmonary diseases and disorders, 3rd ed., Fishman AP, Elias JA et al (Eds), McGraw-Hill, New York, 1998, pp 221-228.
29. FITTING JW. Respiratory muscle fatigue limiting physical exercise? Eur Respir J 1991, 4: 103-108.
30. FOLGERING H, PALANGE P, ANDERSON S. Clinical exercise testing with reference to lung diseases: indications and protocols. In Eur Respir Mon 1997, 6: 51-71.
31. FRASCAROLO P, SCHUTZ Y, JEQUIER E. Anthropometric parameters in the assessment of nutricional status. In Nutrition and ventilatory function. Springer-Verlag 1992, pp 2-12.
32. GORINI M, SPINELLI A, GINANNI R, DURANTI R, GIGLIOTTI F, SCANO G. Neural respiratory drive and neuromuscular coupling in patients with chronic obstructive pulmonary disease (COPD). Chest 1990; 98: 1179-1186.
33. GOSSELINK R, TROOSTERS T, DECRAMER M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
34. HADELI KO, SIEGEL EM, SHERRILL DL, BECK KC, ENRIGHT PL. Predictors of oxygen desaturation during submaximal exercise in 8000 patients. Chest 2001; 120: 88-92.
35. HAJIRO T, NISHIMURA K, TSUKINO M, IKEDA A, KOYAMA H, IZUMI T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185-1189.
36. HAMILTON AL, KILLIAN KJ, SUMMERS E, JONES NL. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
37. HARIK-KHAN RI, FLEG JL, WISE RA. Body mass index and the risk of COPD. Chest 2002; 121: 370-376.
38. JOHNSON BD, WEISMAN IM, ZEBALLOS RJ, BECK KC. Emerging concepts in the evaluation of ventilatory limitation during exercise. The exercise tidal flow-volume loop. Chest 1999; 116: 488-503.
39. JOHNSON MA, WOODCOCK AA, GEDDES DM. Dihydrocodeine for breathlessness in 'pink puffers'. BMJ 1983; 186: 675-677.
40. JONES NL (Ed). Clinical Exercise Testing 4th ed, W. B. Saunders Company, Philadelphia, 1997.
41. JONES NL, MAKRIDES L, HITCHCOCK C et al. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700-708.
42. KAWAKAMI Y, YOSHIKAWA T, SHIDA A, ASANUMA Y, MURAO M. Control of breathing in young twins. J Appl Physiol 1982; 52(3): 537-542.
43. KILLIAN KJ, LEBLANC P, MARTIN DH, SUMMERS E, JONES NL, MORAN CAMPBELL EJ. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
44. KLAS JV, DEMPSEY JA. Voluntary versus reflex regulation of maximal exercise flow/volume loops. Am Rev Respir Dis 1989; 139: 150-156.
45. KOULOURIS NG, DIMOPOULOU I, VALTA P, FINKELSTEIN R, COSIO MG, MILIC-EMILI J. Detection of expiratory flow limitation during exercise in COPD patients. J Appl Physiol 1997; 82(3): 723-731.
46. LEBLANC P, BOWIE DM, SUMMERS E, JONES NL, KILLIAN KJ. Breathlessness and exercise in patients with cardiorespiratory disease. Am Rev Respir Dis 1986; 133: 21-25.
47. MAHLER DA, HARVER A. Prediction of peak oxygen consumption in obstructive airway disease. Med Sci Sports Exerc 1988; 20: 574-578.
48. MAHLER DA, WEINBERG DH, WELLS CK, FEINSTEIN AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85 (6): 751-758.
49. MALTAIS F, LEBLANC P, SIMARD C, JOBIN J, BÉRUBÉ C et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-447.
50. 2 effect on ATP production in exercising muscle of COLD patients: a magnetic resonance spectroscopy study. J Appl Physiol 1995; 78: 2218-2227.
51. MARIN JM, MONTES DE OCA M, RASSULO J, CELLI BR. Ventilatory drive at rest and perception of exertional dyspnea in severe COPD. Chest 1999; 115: 1293-1300.
52. MARTINEZ FJ, MONTES DE OCA M, WHYTE RI, STETZ J, GAY SE, CELLI BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984-1990.
53. MELLENGAARD K. The alveolar-arterial oxygen difference: its size and components in normal man. Acta Physiol Scand 1966; 67: 10.
54. MONTES DE OCA M, CELLI BR. Respiratory muscle recruitment and exercise performance cucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 880-885.
55. MONTES DE OCA M, RASSULO J, CELLI BR. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154: 1284-1289.
56. MORRIS MJ, MADGWICK RG et al. Breathing muscle activity during expiration in patients with chronic airflow obstruction. Eur Respir J 1990; 3: 901-909.
57. MURARIU C, GHEZZO H, MILIC-EMILI J, GAUTIER H. Exercise limitation in obstructive lung disease. Chest 1998; 114: 965-968.
58. MURCIANO D, FERRETTI A, BOCZKOWSKI J, SLEIMAN C, FOURNIER M, MILIC-EMILI J. Flow limitation and dynamic hyperinflation during exercise in COPD patients after single lung transplantation. Chest 2000; 118: 1248-1254.
59. MURRAY CJL, LOPEZ AD. Evidence-based health policy. Lessons from the global burden of disease study. Science 1996; 274: 740-743.
60. NATIONAL HEART, LUNG AND BLOOD INSTITUTE/WORLD HEALTH ORGANIZATION. GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop report, Publication number 2701, April 2001
61. NEUPARTH N. Hiperinsuflação pulmonar crónica. Um estudo na criança asmática. - Dissertação de candidatura ao grau de Doutor em Medicina (Fisiopatologia), Lisboa 1995.
62. NEWELL SZ, MCKENZIE DK, GANDEVIA SC. Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation. Thorax 1989; 44: 903-912.
63. O'DONNELL DE, BAIN DJ, WEBB KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am R Respir Crit Care Med 1997; 155: 530-535.
64. O'DONNELL DE, CHAU LKL, BERTLEY JC, WEBB KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-115.
65. O'DONNELL DE, D'ARSIGNY C, WEBB K. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-898.
66. O'DONNELL DE, LAM M, WEBB KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-549.
67. O'DONNELL DE, REVILL SM, WEBB KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770-777.
68. O'DONNELL DE, SANII R, ANTHONISSEN NR, YOUNES M. Effect of dynamic airway compression on breathing pattern and respiratory sensation in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 135: 912-8.
69. O'DONNELL DE, SANII R, GIESBRECHT G, YOUNES M. Effect of continuous positive airway pressure on respiratory sensation in patients with chronic obstructive pulmonary disease during submaximal exercise. Am Rev Respir Dis 1988; 138: 1185-1191.
70. O'DONNELL DE, SANII R, YOUNES M. Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure. Am Rev Respir Dis 1988; 138: 1510-1514.
71. O'DONNELL DE, WEBB KA, BERTLEY JC, CHAU LKL, CONLAN AA. Mechanism of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysemia. Chest 1996; 110: 18-27.
72. O'DONNELL DE, WEBB KA. Exertional breathlessness in patients with chronic airflow limitations. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-1357.
73. O'DONNELL DE. Breathlessness in patients with chronic airflow limitations. Mechanisms and management. Chest 1994; 106: 904-912
74. PALLENGE P, FORTE S, FELLI A, GALASSETTI P, SERRA P, CARLONE S. Nutritional state and exercise tolerance in patients with COPD. Chest 1995; 107: 1206-1212.
75. PALANGE P, FORTE S, ONORATI P, PARAVATI V, MANFREDI F, SERRA P, CARLONE S. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest 1998; 114: 12-18.
76. PELLEGRINO R, VILLOSIO C, MILANESE U, GARELLI G, RODARTE JR, BRUSASCO V. Breathing during exercise in subjects with mild-to-moderate airflow obstruction: effects of physical training. J Appl Physiol 1999; 87 (5): 1697-1704.
77. PINEDA H, HAAS F, AXEN K, HAAS A. Accuracy of pulmonary function tests in predicting exercise tolerance in chronic obstructive pulmonary disease. Chest 1984; 88 (4): 564-567.
78. PINTO P, MINEIRO A, MOTA T, LOUSADA N, MARTINS CORREIA JF. Provas de esforço cardiopulmonares: o seu papel na clínica. HIV 1995; 4: 225-230.
79. POLKEY MI, KYROUSSIS D, KEILTY SEJ, HAMNEGARD CH, MILLS GH, GREEN M, MOXHAM J. Exhaustive treadmill exercise does not reduce twitch transdiaphragmatic pressure in patients with COPD. Am J Respir Crit Care Med 1995; 152: 959-964.
80. POLKEY MI, KYROUSSIS D, MILLS GH, HAMNEGARD C-H, KEILTY SEJ, GREEN M, MOXHAM J. Inspiratory pressure support reduces slowing of inspiratory muscle relaxation rate during exhaustive treadmill walking in severe COPD. Am J Respir Crit Car Med 1996; 154: 1146-1150.
81. PUNZAL PA, RIES AL, KAPLAN RM, PREWITT LM. Maximum intensity exercise training in patients with chronic obstructive pulmonary disease. Chest 1991; 100: 618-623.
82. QUANJER PH (Ed). Standardized lung function testing. Report Working Party. Standardized of luna function tests. European Community for Coal and Steel. Bull Europ Physiopath Respir 1983; 19 (suppl 5: 1-82.
83. ROCHESTER DF. The diaphram in COPD. Better than expected, but not good enough. NEJM 1991, 325 (13): 961-962.
84. RODRIGUES F. Manual de procedimentos do laboratório de função respiratória. Contributo para a unifomização de procedimentos. Rev Port Pneumol 2000, VI (1): 5-76.
85. RUPPEL GL (Ed). Manual of pulmonary function testing. 7th edition, Mosby Ed, St Louis 1997.
86. SCHOLS AM, SOETERS PB, MOSTERT R, PLUYMERS RJ, WOUTERS EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268-1274.
87. STUBBING DG et al. Pulmonary mechanisms during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49: 511-515.
88. TJAHAJA IE, REDDY HK, JANICKI JS, WEBER KT. Evolving role of cardiopulmonary exercise testing in cardiovascular disease in Weisman IM, Zeballos RJ (Eds). Clinical Exercise Testing Clin Chest Med 1994; 15 (2): 271-285.
89. TOBIN MJ. Respirtory muscles in disease. Clin Chest Med 1988; 9: 263-86.
90. TORRES S, CONDE S, BARROSO A. Avaliação da qualidade de vida na Suberose (dados preliminares). Índice de dispneia basal modificado (Mahler) e Índice de Dispneia de Transição. Rev Port Pneumol 1996, II (6 Supl. I), Anexo no 6: 59-71.
91. VAN MEERHAEGHE A, SERGYSELS R. Control of breathing during exercise in patients with chronic airflow limitations with or without hypercapnia. Chest 1983; 84 (5): 565-570.
92. WASSERMAN K, HANSEN JE, SUE DY, CASABURI R, WHIPP BJ. Principles of exercise testing and interpretation including pathophysiology and clinical applications. Third edition. 1999. Lippincott Williams and Wilkins, Philadelphia.
93. WEISMAN IM, ZEBALLOS RJ. Cardiopulmonary exercise testing. Pulmonary and critical care update (PCCU) 1995; 11 (2): 1-8.
94. WHIPP BJ, WAGNER PD, AGUSTÍ A. Factors determining the response to exercise in healthy subjects in Roca J, WHIPP BJ (Eds). Clinical exercise testing. Eur Respir Mon. 1997, 6: 3-31.
95. WIJKSTRA PJ, JONES PW. Quality of life in patients with chronic obstructive pulmonary disease in Postma DS, Siafakas NM (eds). Management of chronic obstructive pulmonary disease. Eur Resp Mon 1998; 7: 235-246.
96. WILSON DO, ROGERS RM, WRIGHT EC, ANTHONSEN NR. Body weight in COPD: the NIH intermittent positive pressure breathing trial. Am Rev Respir Dis 1989; 139: 1435-1438.